Skip to main content

Herbert Timothy P.'s Form 4 filing

Inspire Medical Systems, Inc. (INSP) · filed Feb 10, 2023

Accession no.
0001104659-23-018715
Filed
Feb 10, 2023
Trade date
Nov 8, 2022-Feb 9, 2023
Filing delay
94 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market sales total $2.90M. It was filed 94 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Herbert Timothy P.CIK 0001737136Director, Officer (CEO and President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 8, 2022Common StockGGiftDisposed−2,000$0.00$020,641Indirect
Feb 8, 2023Common StockSSaleDisposed−3,500$275.00−$962,50019,375Indirect
Feb 9, 2023Common StockSSaleDisposed−7,028$275.12F4−$1,933,543.3612,347Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.61, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)